Navigation Links
Inovio Initiates H1N1 Universal Influenza Vaccine Clinical Trial Targeting Over-65 Population, Which Represents 90% of Flu Deaths
Date:7/10/2012

BLUE BELL, Pa., July 10, 2012 /PRNewswire/ -- Inovio Pharmaceuticals, Inc. (NYSE MKT: INO) announced today that the first patients have been treated in a clinical trial evaluating immune responses in elderly adults immunized with Inovio's H1N1 SynCon® universal influenza vaccine. This phase I study will evaluate the ability of Inovio's SynCon® vaccine alone as well as in combination with the 2012 seasonal influenza vaccine to generate: protective levels of immune responses; antigen-specific antibody immune responses against unmatched influenza strains; and T-cell immune responses that may be helpful in fighting influenza.

The population most susceptible to influenza, those over 65 years of age, represent about 90% of annual influenza deaths in the US. Older people's immune systems typically mount weaker immune responses to vaccines. There is consequently a need for new vaccine technology able to stimulate a broader immune response that is capable of protecting against influenza strains not specifically matched to the strain(s) represented in the vaccine.

The phase I open label study will take place at the University of Manitoba in Winnipeg, Canada, funded in part by a grant from the Canadian Institute of Health Research. In the trial, 50 healthy elderly patients will be divided into three groups: One group of 20 subjects will receive a 2 dose regimen of Inovio's H1N1 SynCon® flu vaccine delivered using Inovio's proprietary CELLECTRA® intradermal electroporation device; a second group of 20 subjects will receive one dose of Inovio's SynCon® vaccine delivered using electroporation followed by a dose of the 2012 trivalent seasonal flu vaccine 24 weeks later; a third group  of 10 subjects will receive a placebo delivered by electroporation followed by a dose of the seasonal flu vaccine 24 weeks later. The study will assess the tolerability, safety, and the immune responses of the different vaccination regimens. See the de
'/>"/>

SOURCE Inovio Pharmaceuticals, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related medicine technology :

1. Inovio Pharmaceuticals to Present at JMP Investor Conference
2. Inovio Pharmaceuticals Universal Avian Flu Vaccine Generates Protective Antibody Responses Against Six H5N1 Viruses in Phase I Trial
3. Inovio Pharmaceuticals to Present at SPI 2012
4. Inovio Pharmaceuticals Reports 2012 First Quarter Financial Results
5. Inovio Pharmaceuticals Granted U.S. Patent Protection for Synthetic Vaccine for Cervical Dysplasia and Cancer
6. Stryker Initiates Voluntary Product Recall of Modular-Neck Stems
7. MAQUET Initiates Class I Recall of the FLOW-i Anesthesia System
8. Oncos Therapeutics Initiates Phase I Clinical Study of CGTG-102, an Oncolytic Adenovirus for the Treatment of Solid Tumor Cancers
9. Alder BioPharmaceuticals Inc. Initiates Phase 1 Clinical Study of Antibody Therapeutic Candidate for Treatment of Migraine, ALD403
10. Isis Initiates Phase 2 Study of ISIS-APOCIIIRx in Patients with Hypertriglyceridemia
11. CSL Behring Initiates Study of Subcutaneous Administration of C1-esterase Inhibitor in Patients with Hereditary Angioedema
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/22/2014)... -- Sutro Biopharma today announced that it has been named ... 15 biotechnology companies, designating it as one of the ... "Sutro has earned some careful attention from ... partners for what promises to be a next-gen approach ... Carroll , editor of FierceBiotech .  "This is ...
(Date:9/22/2014)... 2014 Arena Pharmaceuticals, Inc. (NASDAQ: ... present a corporate overview and update at the NewsMakers ... 2014, at 11:30 a.m. Eastern Time (8:30 a.m. Pacific ... New York City . A live ... the investor relations section of Arena,s website at ...
(Date:9/22/2014)... YORK , Sept. 22, 2014 ... exclusive, global license agreement with Plasma Technologies LLC ... proprietary plasma fractionation process. Concurrently, the Company announced ... to strategically refocus and rebrand the company as ... a national listing for its common shares. ...
Breaking Medicine Technology:FierceBiotech names Sutro Biopharma as one of its "Fierce 15" Biotech Companies of 2014 2FierceBiotech names Sutro Biopharma as one of its "Fierce 15" Biotech Companies of 2014 3Arena Pharmaceuticals to Present at the NewsMakers in the Biotech Industry Conference 2Arena Pharmaceuticals to Present at the NewsMakers in the Biotech Industry Conference 3Access Pharmaceuticals Announces Exclusive Global Plasma Therapeutics License, New Management And New Corporate Name 2Access Pharmaceuticals Announces Exclusive Global Plasma Therapeutics License, New Management And New Corporate Name 3Access Pharmaceuticals Announces Exclusive Global Plasma Therapeutics License, New Management And New Corporate Name 4Access Pharmaceuticals Announces Exclusive Global Plasma Therapeutics License, New Management And New Corporate Name 5Access Pharmaceuticals Announces Exclusive Global Plasma Therapeutics License, New Management And New Corporate Name 6
... , SEATTLE , Feb. 11 ... systems, today announced record 2009 sales results. The successful launch ... growth in excess of 75% and the company,s first cash ... consumed the company,s manufacturing capacity for 2009 and well into ...
... DENVER , Feb. 11 Corgenix Medical Corporation ... test kits, today filed its 2nd quarter Form 10-Q and reported ... declined during the quarter but slightly increased for the six months ... by the report are as follows: , Revenues for the ...
Cached Medicine Technology:Amnis Announces Record 2009 Sales 2Corgenix Reports Second Quarter Fiscal 2010 Financial Results 2Corgenix Reports Second Quarter Fiscal 2010 Financial Results 3Corgenix Reports Second Quarter Fiscal 2010 Financial Results 4
(Date:9/23/2014)... September 23, 2014 Ale Gicqueau, President ... on Advanced Data Visualization for Clinical Trials at the ... in San Francisco on Friday, September 26, 2014. ... volunteers. Since its inception, PhUSE has expanded from its ... a global platform for the discussion of topics encompassing ...
(Date:9/23/2014)... 23, 2014 WetKeys Washable Keyboards announces ... in their industrial keyboards line. Labeled ... to last longer in heavy-duty industrial computing for the ... where grease and oil can destroy usability or cause ... constant threat to the longevity of computer equipment and ...
(Date:9/23/2014)... September 23, 2014 With the emergence ... sale of all tobacco products, retail chains are transforming ... services to patients, customers, and shoppers. In this capacity, ... of retail pharmacy healthcare to share their knowledge on ... to know to coordinate care with other colleagues inside ...
(Date:9/23/2014)... Névo takes a bold step forward in fitness ... activity tracking and phone notifications for a fashion conscious ... and more. , http://www.nevowatch.com , “Today, ... their busy lives to look and feel better. The ... results, but until now, style played a distance second ...
(Date:9/23/2014)... 23, 2014 Published by Nationwide Lifts, the ... to take charge of their mobility in a new way, ... impactful. Stair lifts are that equipment and can ... in the elevator business, I’ve seen so many ... or a loved one with mobility issues,” said Andy Darnley, ...
Breaking Medicine News(10 mins):Health News:Clinovo Sponsors and Presents at Pharmaceutical Users Software Exchange (PhUSE) SDE in San Francisco 2Health News:WetKeys Announces New Oil Resistant Keyboard for Industrial Computing, Food Processing Plants, Automotive Factories and Machine Shops 2Health News:WetKeys Announces New Oil Resistant Keyboard for Industrial Computing, Food Processing Plants, Automotive Factories and Machine Shops 3Health News:WetKeys Announces New Oil Resistant Keyboard for Industrial Computing, Food Processing Plants, Automotive Factories and Machine Shops 4Health News:WetKeys Announces New Oil Resistant Keyboard for Industrial Computing, Food Processing Plants, Automotive Factories and Machine Shops 5Health News:Retail Pharmacies at the Forefront of Primary Care Innovation 2Health News:Nevo changes the face of fitness wearables with an analogue watch combining activity tracking, phone notifications, and LED goal progress indicators for active lifestyles 2Health News:Nevo changes the face of fitness wearables with an analogue watch combining activity tracking, phone notifications, and LED goal progress indicators for active lifestyles 3Health News:Nationwide Lifts, America’s Leader in Home Elevators, Is Proud to Announce the Release of Its First Book, “Stair Lifts: Move Up, Not Out!” 2
... ... ... , ... , , , ...
... ... ... ... ...
... Tiny bits of molecular "trash" found in circulating blood ... untimely death, say researchers at Duke University Medical Center. ... issue of the journal Circulation Genetics , comes ... disease, and is the first to identify specific metabolic ...
... tests with rats, tea consumption reduced oxidative stress, researchers say ... green tea work their way into the tissues of the ... researchers say. , The findings, published in the current ... , suggest that the substances, known as catechins, are absorbed ...
... could work, but application remains years away , FRIDAY, Feb. ... first to hint that gene therapy could become a weapon ... remains far from being ready for use by patients, and ... is "a step in the direction of using gene therapy" ...
... ... , ... ... TROY, Mich. , Feb. 19 Joseph F. Page will be a guest speaker at the University of Michigan on ...
Cached Medicine News:Health News:RetireSafe Survey Says Seniors Are Struggling With Increased Costs Without an Increased Social Security Cost of Living Adjustment 2Health News:RetireSafe Survey Says Seniors Are Struggling With Increased Costs Without an Increased Social Security Cost of Living Adjustment 3Health News:Cunard's Queen Victoria is 'Pretty in Pink' in Sydney 2Health News:Tiny molecules may tell big story about cardiovascular disease risk 2Health News:Tiny molecules may tell big story about cardiovascular disease risk 3Health News:Gene Therapy Shows Promise Against HIV 2Health News:Giarmarco, Mullins & Horton, P.C. President Joseph F. Page to Speak at University of Michigan 2
... national reference laboratory and a worldwide leader ... offers an extensive test menu of highly ... and anatomic pathology. Owned by the University ... than half of the nation's university teaching ...
... a national reference laboratory and a worldwide ... ARUP offers an extensive test menu of ... clinical and anatomic pathology. Owned by the ... more than half of the nation's university ...
... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
... reference laboratory and a worldwide leader in ... an extensive test menu of highly complex ... anatomic pathology. Owned by the University of ... half of the nation's university teaching hospitals ...
Medicine Products: